Factors associated with seronegative chronic hepatitis C virus infection in HIV infection
about
Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progressionFactors Associated with Prevalent Hepatitis C Infection Among HIV-Infected Women with No Reported History of Injection Drug Use: The Women's Interagency HIV Study (WIHS)Systematic review and meta-analysis of hepatitis C virus infection and HIV viral load: new insights into epidemiologic synergyClinical variables identify seronegative HCV co-infection in HIV-infected individuals.Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study.Hepatitis C virus infection in the human immunodeficiency virus infected patient.Vertical transmission of hepatitis C virus: Current knowledge and perspectivesRapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection.The effects of opiate use and hepatitis C virus infection on risk of diabetes mellitus in the Women's Interagency HIV Study.Hepatitis B and C infection and liver disease trends among human immunodeficiency virus-infected individuals.High rate of seronegative HCV infection in HIV-positive patients.Cost-effectiveness and population outcomes of general population screening for hepatitis C.Seronegative hepatitis C virus infection in a child infected via mother-to-child transmissionHigh Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany.Opportunities in proteomics to understand hepatitis C and HIV coinfection.Seronegative hepatitis C virus infection.Update on donor-derived infections in liver transplantation.Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV.Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life.Active co-infection with HBV and/or HCV in South African HIV positive patients due for cancer therapy.Need for improvements in the surveillance and management of chronic viral hepatitis in HIV patients followed in a Danish outpatient clinic.Seronegative hepatitis C virus infection in patients with lymphoproliferative disorders.Hepatitis E virus infection in patients infected with the human immunodeficiency virus.Effect of antiretroviral therapy and hepatitis c co-infection on changes in lipid levels in HIV-Infected patients 48 weeks after initiation of therapy.The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity.
P2860
Q27485372-C2F1959E-7C73-4E39-98AB-E0FC5885FED2Q27490928-64767BA2-4031-4264-B074-E03A351ACCDCQ28077305-08B60844-ED33-41FB-9EE5-28E7817AF110Q33397264-B767B218-CEA3-41D9-8B22-3EC9762FB4B8Q33435099-7BC8D9C3-1F72-4C5C-A2BA-5D5E0DB4ACDBQ34168504-704D6E38-DF3F-4123-949F-6784F42E38C2Q34263352-D19B34CE-6506-4CD6-BF77-5C76FC0D4BDAQ34522213-86F9CBB8-3DB2-4F0F-89FA-7DEE64FD8D98Q34753973-93E7368A-1809-46F3-B4EE-A9C8C92734ADQ34831090-A7A91E21-F46A-46AC-9B34-72E134288015Q35125655-1857C486-51B8-4307-A1DA-443D774E7ADBQ36115516-DCDF3D7F-EE7D-4818-B6D5-E1D31A7ECDA8Q36118771-3AE491D0-EA3A-4497-9D67-987F120FC1EAQ36268801-A7931D96-CE86-410E-9888-CB801E5E5F00Q36344202-187F450E-6EB5-408B-B285-1626A026B8B3Q37631608-D57B5219-DE75-46C8-B7EA-513DD79F73B5Q38092789-4750E1DE-8E0F-414F-9E1D-895BAA016663Q38423867-730815AF-F049-4442-AF88-C51555D40385Q39244103-AD0D21E5-22EC-482E-958A-968FCF2AD738Q41505058-EFDA2C50-4F99-433A-B62B-1F9A6C94E8B3Q42197952-C18038E4-594B-4865-94E5-3AC6639A7E24Q42210274-25FE1F27-0DC6-41A7-9315-1A0670207621Q42243752-9096ADDD-29F5-4CE7-BDA3-1A0B4D2C329AQ45364186-D0EBB200-95E8-4282-B411-53A3735D8411Q46879484-25CB1153-7E03-494A-B11C-91C58537EAEEQ53075373-9A4F8596-18FE-4638-A73E-128A4B2B3807
P2860
Factors associated with seronegative chronic hepatitis C virus infection in HIV infection
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Factors associated with seronegative chronic hepatitis C virus infection in HIV infection
@ast
Factors associated with seronegative chronic hepatitis C virus infection in HIV infection
@en
type
label
Factors associated with seronegative chronic hepatitis C virus infection in HIV infection
@ast
Factors associated with seronegative chronic hepatitis C virus infection in HIV infection
@en
prefLabel
Factors associated with seronegative chronic hepatitis C virus infection in HIV infection
@ast
Factors associated with seronegative chronic hepatitis C virus infection in HIV infection
@en
P2093
P2860
P356
P1476
Factors associated with seronegative chronic hepatitis C virus infection in HIV infection
@en
P2093
Christopher Hall
E Turner Overton
Gabriel Chamie
Jack T Stapleton
Maurizio Bonacini
Phyllis C Tien
Rebecca Scherzer
P2860
P304
P356
10.1086/511038
P407
P577
2007-01-10T00:00:00Z